Moreover, STAT3/Rabs-mediated exosome release was correlated with a more aggressive and chemoresistant cancer phenotype under hypoxic conditions [53] and a recent study demonstrated a role for Rab18 in resistance to cisplatin-induced apoptosis [54]. This evidence concerns the gene RAB18 and cancer.